FAQs about the Inflation Reduction Act’s Medicare Drug Price Negotiation Program
(By Juliette Cubanski for the Kaiser Family Foundation published August 8, 2023) The Inflation Reduction Act of 2022 (the Act),
Read More
CMS
The Real Costs of the New Alzheimer’s Drug, Most of Which Will Fall to Taxpayers
(By Arthur Allen for KFF Health News) The first drug purporting to slow the advance of Alzheimer’s disease is likely
Read MoreGuiding an Improved Dementia Experience
The Centers for Medicare & Medicaid Services (CMS) announced its new dementia care model. The model, Guiding an Improved Dementia
Read MoreCMS projects slightly lower Medicare Part D premiums in 2024
(By Rylee Wilson for Becker’s Hospital Review) CMS is projecting Medicare Part D premiums to decrease by 1.8 percent in
Read MoreHow Do Dual-Eligible Individuals Get Their Medicare Coverage?
(By Maria T. Peña, Maiss Mohamed, Jeannie Fuglesten Biniek, Juliette Cubanski, and Tricia Neuman for Kaiser Family Foundation Published: Jul
Read MoreCalifornia to eliminate asset tests for Medicaid
(By Rylee Wilson for Becker’s Hospital Review) CMS has approved a proposal from California to eliminate asset tests for Medicaid
Read MoreWhat’s a fair price for a prescription drug? Medicare’s about to weigh in
(By Leslie Walker and Dan Gorenstein for NPR) Drugmakers around the globe are bracing for a major shakeup in how
Read MoreKey Facts About Medicare Part D Enrollment and Costs in 2023
(By Juliette Cubanski and Anthony Damico for Kaiser Family Foundation Published: Jul 26, 2023) The Medicare Part D program provides
Read MoreMedicare Advantage prior authorization reform bill passes House committee
(By Andrew Cass for Becker’s Hospital Review) A bill aiming to reform the Medicare Advantage prior authorization process was included
Read MoreNew Weight Loss Drugs Carry High Price Tags and Lots of Questions for Seniors
(By Judith Graham for KFF Health News) Corlee Morris has dieted throughout her adult life. After her weight began climbing
Read More